enGene Holdings (ENGN) Metrics: History & Chart

enGene Holdings Inc.(ENGN)

Biotechnology · Montreal, QC

$1.84-0.03 (-1.67%)

Delayed quote: Oct 6, 2026, 11:39 AM EDT

About enGene Holdings Inc.

Operating through its subsidiary, enGene, Inc., enGene Holdings Inc. functions as a clinical-stage biotechnology firm. Its core mission involves pioneering genetic pharmaceuticals, achieved by administering therapeutic agents directly to mucosal tissues and other bodily organs. A key asset in its pipeline is EG-70, also known as detalimogene voraplasmid. This innovative non-viral immunotherapy is being developed to treat non-muscle invasive bladder cancer in patients diagnosed with carcinoma-in-situ (Cis) who have shown no improvement after Bacillus Calmette-Guérin therapy. The company was established in 2023 and is headquartered in Saint-Laurent, Canada.

Montreal, QC

82 employees

www.engene.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Ronald H. W. Cooper

View full financials

Third-Party DCF Estimate (FMP)	$0.28
Price Gap vs Third-Party Estimate	-85.16%

7D Total Return	-5.08%
30D Total Return	+2.75%
YTD Total Return	-79.29%
1Y Total Return	-75.87%
3Y Total Return	N/A
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-79.29%
2025	+35.79%
2024	-27.95%
2023	N/A
2022	N/A
2021	N/A

CAGR TTM	-75.71%
CAGR 3Y	N/A
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

ENGN Valuation Metrics

ENGN Stock Price Metrics

ENGN Dividend Metrics

ENGN Growth Rate Metrics

ENGN Discounted Cash Flow Metrics

ENGN Returns By Period

ENGN Yearly Returns

ENGN Average Annual Returns By Period (CAGR)

ENGN Revenue Metrics

ENGN PE Ratio Metrics

ENGN PS Ratio Metrics

ENGN PB Ratio Metrics

ENGN Price to Free Cash Flow Ratio Metrics

ENGN Debt to Equity Ratio Metrics

ENGN PEG Ratio Metrics

ENGN FCF Yield

ENGN Earnings Yield

ENGN EBITDA Yield

ENGN OCF Yield

ENGN EV/EBIT Ratio Metrics

ENGN EV/EBITDA Ratio Metrics

ENGN EV/Assets Ratio Metrics

ENGN EV/Sales Ratio Metrics

ENGN Current Ratio Metrics

ENGN Quick Ratio Metrics

ENGN ROIC Metrics

ENGN Return on Assets Metrics

ENGN Return on Equity Metrics

ENGN Net Profit Margin Metrics

ENGN Gross Profit Margin Metrics

ENGN Tax Rate Metrics

PS Ratio	N/A
PS Ratio Avg TTM	N/A
PS Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PB Ratio	0.57
PB Ratio Avg TTM	1.52
PB Ratio Avg 3Y	1.35
Current VS TTM Avg	-62.55%
Current VS 3Y Avg	-57.93%
Current VS 5Y Avg	-57.93%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.14
Debt/Equity Ratio Avg TTM	0.15
Debt/Equity Ratio Avg 3Y	0.13
Current VS TTM Avg	-2.38%
Current VS 3Y Avg	+14.47%
Current VS 5Y Avg	+56.20%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.43
Ev/Assets Ratio Avg TTM	1.20
Ev/Assets Ratio Avg 3Y	0.98
Current VS TTM Avg	-64.02%
Current VS 3Y Avg	-55.97%
Current VS 5Y Avg	-55.97%

Ev/Sales Ratio	N/A
Ev/Sales Ratio Avg TTM	N/A
Ev/Sales Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Current Ratio	10.21
Current Ratio Avg TTM	10.23
Current Ratio Avg 3Y	13.33
Current VS TTM Avg	-0.20%
Current VS 3Y Avg	-23.37%
Current VS 5Y Avg	+16.22%

Quick Ratio	10.21
Quick Ratio Avg TTM	10.23
Quick Ratio Avg 3Y	13.33
Current VS TTM Avg	-0.20%
Current VS 3Y Avg	-23.36%
Current VS 5Y Avg	+16.23%

ROIC	(1.78%)
ROIC Avg 3Y	(26.50%)
ROIC Avg 5Y	(28.27%)
Current VS 3Y Avg	+93.29%
Current VS 5Y Avg	+93.71%
Current VS 10Y Avg	+93.71%

ROA	(1.70%)
ROA Avg TTM	(3.33%)
ROA Avg 3Y	(8.67%)
Current VS TTM Avg	+48.90%
Current VS 3Y Avg	+80.38%
Current VS 5Y Avg	+75.71%

ROE	(2.13%)
ROE Avg TTM	(37.76%)
ROE Avg 3Y	(35.65%)
Current VS TTM Avg	+94.36%
Current VS 3Y Avg	+94.02%
Current VS 5Y Avg	+93.83%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	0.00%
Tax Rate Avg 3Y	0.00%
Tax Rate Avg 5Y	0.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A